Nkiruka Arene, MD
Physical Medicine & Rehabilitation · Bel Air, MDNPI 1477517332
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 32.5% of the total.
Across 132 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$850
- Indivior Inc.$224
- Collegium Pharmaceutical, Inc.$164
- Medtronic$163
- Flowonix Medical Incorporated$131
- Lilly USA, LLC$122
- plus $964 from 25 others
What the payments were for
- Food & beverage$2,619100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 52 | $850 |
| Indivior Inc. | 10 | $224 |
| Collegium Pharmaceutical, Inc. | 8 | $164 |
| Medtronic | 2 | $163 |
| Flowonix Medical Incorporated | 1 | $131 |
| Lilly USA, LLC | 8 | $122 |
| Orexo US, Inc. | 7 | $115 |
| Braeburn Inc. | 4 | $84 |
| Tersera Therapeutics LLC | 4 | $80 |
| Lundbeck LLC | 3 | $78 |
| Pfizer | 5 | $75 |
| Neurocrine Biosciences, Inc. | 2 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $47 |
| Kaleo, Inc. | 3 | $45 |
| Bausch Health US, LLC | 2 | $43 |
| Boston Scientific | 1 | $35 |
| Revance Therapeutics, Inc. | 1 | $34 |
| Scilex Pharmaceuticals Inc. | 2 | $33 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Tonix Medicines, Inc. | 1 | $25 |
| Novartis | 1 | $23 |
| Amgen | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Valinor Pharma, LLC | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Dynasplint Systems Inc. | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
| Bioventus LLC | 1 | $12 |
| MDD US Operations, LLC | 1 | $11 |
| GRT US Holding, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prometra II$131
How this compares
$2,619 in reported general payments places this provider in the 85th percentile of 202 physical medicine & rehabilitation providers in Maryland.
See all physical medicine & rehabilitation providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BotoxOnabotulinumtoxina | 19 | $33,314 |
| Xtampza ErOxycodone Myristate | 15 | $6,276 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $4,703 |
| Oxycodone Hcl | 177 | $3,037 |
| Diclofenac Sodium | 27 | $1,877 |
| Gabapentin | 72 | $1,083 |
| Baclofen | 30 | $1,074 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $978 |
| Pregabalin | 48 | $762 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $674 |
| Tizanidine Hcl | 32 | $332 |
| Mirtazapine | 13 | $328 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 15 | $275 |
| Cyclobenzaprine Hcl | 26 | $258 |
| Duloxetine Hcl | 15 | $246 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieBotox | $850 | $33,31419 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $164 | $6,27615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 202 physical medicine & rehabilitation providers in Maryland.
Other physical medicine & rehabilitation in Bel Air
- Robert TsujiBel Air$5K
- Rehan KhanBel Air$2K
- David ReeceBethesda$719K
- Gurtej SinghCatonsville$205K
- Akhil ChhatreBaltimore$169K
- Justin WassermanBethesda$51K
- Vivek SindhiGlen Burnie$33K
- Inai MkandawireOwings Mills$23K
- Cheryl MejiaHagerstown$20K
- Ronald ShinBaltimore$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.